Explore more publications!

Tech Press of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Press of Togo.

Press releases published on February 27, 2026

Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders
ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC
Certara to Participate in Upcoming Investor Conferences
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum
reAlpha Tech Corp. Appoints Thomas Kutzman as Chief Financial Officer to Support Growth Strategy
Duos Technologies Group, Inc. Signs ~$200M LOI and Appoints Doug Recker as CEO
AlloX Launches AI-Powered Investment Platform with $25,000 USDT Prize Pool for Early Participants
Flux, the AI hardware engineer, announces $37M in new investment
Vertex to Present at Upcoming Conferences
VisionWave Holdings, Inc. Enters into Memorandum of Understanding to Pursue German Defense Market Opportunities
Next-Generation Reliability Fuels Rapid Wi-Fi 8 Adoption, Reaching 82.8 Million Annual Shipments by 2030
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Nkarta to Participate in March Investor Conferences
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Provides Patent Portfolio Update; 20 Texatron™ “Clam-Shell” Applications Filed; Significant Portfolio Expansion Planned for 2026
Tidewave Bio Appoints Prof. Alexander M.M. Eggermont, MD, PhD, as Head of Clinical Advisory Board
TransAlta to Host Investor Day
TransAlta Enters Memorandum of Understanding for Data Centre Development at Keephills Site with Potential to Scale Up to 1 GW
TransAlta Reports Fourth Quarter and Year End 2025 Results, Announces Data Centre Agreement, Declares Dividend Increase and Provides 2026 Outlook
Communiqué de presse : Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions